SEHK:3788
SEHK:3788Metals and Mining

China Hanking Holdings (SEHK:3788): Fresh Regulatory Win Prompts a Closer Look at Valuation

China Hanking Holdings (SEHK:3788) has secured regulatory approval from Western Australia to commence dewatering at its Golden Pig gold mine. This approval unlocks the next phase of underground mining and could accelerate progress across the larger Cygnet gold project. See our latest analysis for China Hanking Holdings. China Hanking Holdings has been on a tear lately, with its 1-day share price return of 4.82% helping to erase some of the recent pullback. Despite some short-term volatility,...
SEHK:2338
SEHK:2338Machinery

Weichai Power (SEHK:2338) Is Up 6.6% After Reporting Higher Nine-Month Sales and Earnings—What's Changed

Weichai Power Co., Ltd. reported earnings for the nine months ended September 30, 2025, posting sales of CNY 170.57 billion and net income of CNY 8.88 billion, both higher than the same period last year. The results showed an increase in both revenue and basic earnings per share from continuing operations, highlighting ongoing improvement in profitability and operational scale. With solid gains in sales and earnings, we'll examine how Weichai Power's consistent financial growth impacts its...
SEHK:2331
SEHK:2331Luxury

Li Ning (SEHK:2331): Assessing Valuation After Q3 2025 Earnings Call Spurs Investor Focus

Li Ning (SEHK:2331) just held its Q3 2025 earnings call, drawing focused attention from investors and analysts. These quarterly updates provide a revealing look at the company’s financial health and management’s outlook for the months ahead. See our latest analysis for Li Ning. Li Ning’s Q3 earnings call appears to have been a catalyst for movement, with the share price rising 1.75% on the day but pulling back 7.05% over the past week. While short-term volatility remains, the company’s total...
SEHK:9926
SEHK:9926Biotechs

Is Ivonescimab’s Phase III Success Transforming the Investment Case for Akeso (SEHK:9926)?

Summit Therapeutics recently announced that results from multiple Phase III trials of ivonescimab, a first-in-class bispecific antibody developed by Akeso for cancer treatment, were presented at major medical meetings and published in The Lancet, with strong positive findings for non-small cell lung cancer (NSCLC) patients in China. This clinical progress has already contributed to regulatory approval, imminent U.S. regulatory submission, and inclusion in China's National Reimbursement Drug...
SEHK:992
SEHK:992Tech

Is Lenovo a Bargain After AI Expansion Drives 16% Rally in 2025?

Ever wondered if Lenovo Group is truly a bargain, or if the market is missing something big? You are in the right place to dig into what is really driving value for this tech giant. Lenovo Group’s stock has been anything but flat, with a 16.0% year-to-date climb and an impressive 162.2% gain over the last five years, though it dipped -1.4% this week as the market recalibrated expectations. Global headlines have swirled around Lenovo's expansion in AI-powered devices and fresh investment in...
SEHK:1952
SEHK:1952Biotechs

What Everest Medicines (SEHK:1952)'s Exclusive VIS-101 Ophthalmology License Means for Shareholders

In late October 2025, Everest Medicines announced it had acquired an exclusive license to develop, manufacture, and commercialize VIS-101, a bifunctional biologic for wet AMD, diabetic macular edema, and retinal vein occlusion, in Greater China, Singapore, South Korea, and Southeast Asia through a collaboration with Visara, Inc. This marks Everest Medicines' entry into ophthalmology, adding a late-stage asset expected to be Phase-3-ready in 2026 and enhancing its portfolio diversification...
SEHK:66
SEHK:66Transportation

How MTR’s US$25 Billion Debt Programme May Shape Financial Flexibility for Investors (SEHK:66)

MTR Corporation Limited recently announced a US$25 billion debt issuance programme with an application for listing on the Hong Kong Stock Exchange, available for 12 months from October 31. This substantial planned capital raise highlights MTR's intent to secure funding for future development, operational support, or potential refinancing amid changing market conditions. We'll assess how this significant debt programme may influence MTR's future financial flexibility and reshape its long-term...
SEHK:9676
SEHK:9676Food

Why Shiyue Daotian Group (SEHK:9676) Is Up 10.4% After Q3 Profit Surges on Marketing Success

Shiyue Daotian Group Co., Ltd. reported substantial year-on-year growth in the third quarter of 2025, with revenues rising by more than 25% and operational profits increasing by over 70% compared to the same period last year. These improvements were driven by the launch of ‘Fresh Rice Season’ marketing activities, which strengthened the brand and expanded the company’s retail and instant retail presence. We’ll examine how Shiyue Daotian Group’s effective marketing push and rapid profit...
SEHK:2618
SEHK:2618Logistics

Will Southeast Asia Expansion and Deppon Updates Change JD Logistics' (SEHK:2618) Narrative?

JD Logistics recently announced that its board will convene on November 13, 2025, to review and approve unaudited results for the third quarter ended September 30, 2025, while its supply chain arm JoyLogistics introduced integrated delivery and installation services for bulky items in Malaysia and Singapore. This expansion into Southeast Asia, coupled with operational updates for its key subsidiary Deppon, draws attention to both growth opportunities and ongoing challenges for JD Logistics...
SEHK:579
SEHK:579Renewable Energy

Beijing Jingneng Clean Energy (SEHK:579): Expanding Margins Reinforce Investor Optimism Despite Slower Growth

Beijing Jingneng Clean Energy (SEHK:579) posted stable earnings, with average earnings growth of 6.5% per year over the past five years and net profit margins improving from 14.4% to 14.9%. Earnings growth for the most recent year came in at 5.8%, slightly below the company’s longer-term pace. Future earnings are forecast to increase 8.43% per year and revenue is expected to grow at 3.7% per year. Investors will likely focus on the company’s steady profit and revenue performance, as well as...
SEHK:1798
SEHK:1798Renewable Energy

Datang Renewable (SEHK:1798) Margin Compression Tempers Bullish Growth Narrative Despite 19% Earnings Forecast

China Datang Corporation Renewable Power (SEHK:1798) is guiding for earnings growth of about 19% annually, easily outpacing both the Hong Kong market’s 12% average and the expected 8.6% for market revenue. The company’s current net profit margin sits at 13.2%, a compression from last year’s 14.9%, while average annual earnings growth over the past five years has been 7.9%. With these numbers illustrating robust forward expectations but pointing to mixed margin dynamics, investors are...
SEHK:1368
SEHK:1368Luxury

Should Xtep International Holdings' (SEHK:1368) Convertible Bond Adjustment After Dividend Prompt a Closer Look From Investors?

Xtep International Holdings Limited recently adjusted the conversion prices of its 2021, 2024, and 2025 Convertible Bonds following the declaration and payment of its 2025 Interim Dividend, with these changes already put into effect. This move modifies the conversion terms for bondholders, which could affect future capital structure decisions and influence the investment preferences of existing and potential stakeholders. We will explore how the adjustment of convertible bond conversion...